Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial Complex I deficiency: guilty in Parkinson’s disease
Melissa Vos
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease
Shruti Rajan, Kamatham Pushpa Tryphena, Sabiya Samim Khan, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101915-101915
Closed Access | Times Cited: 42
Mitochondria as intracellular signalling organelles. An update
Lucia‐Doina Popov
Cellular Signalling (2023) Vol. 109, pp. 110794-110794
Open Access | Times Cited: 30
Inflammasome Activation in Parkinson’s Disease
Shannon Jewell, Ashane M. Herath, Richard D. Gordon
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S113-S128
Open Access | Times Cited: 29
Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases
Paula Cilleros-Holgado, David Gómez-Fernández, Rocío Piñero-Pérez, et al.
Biomolecules (2023) Vol. 13, Iss. 12, pp. 1789-1789
Open Access | Times Cited: 17
Targeting Mitochondrial Complex I Deficiency in MPP+/MPTP-induced Parkinson’s Disease Cell Culture and Mouse Models by Transducing Yeast NDI1 Gene
Hongzhi Li, Jing Zhang, Yuqi Shen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 6
The Effect of Neuronal CoQ10 Deficiency and Mitochondrial Dysfunction on a Rotenone-Induced Neuronal Cell Model of Parkinson’s Disease
Lauren Millichap, Nadia Turton, Elisabetta Damiani, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6622-6622
Open Access | Times Cited: 6
Insights into Calpain Activation and Rho-ROCK Signaling in Parkinson’s Disease and Aging
Amy Gathings, Vandana Zaman, Narendra L. Banik, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1074-1074
Open Access | Times Cited: 4
Mitochondria-targeted nanovesicles for ursodeoxycholic acid delivery to combat neurodegeneration by ameliorating mitochondrial dysfunction
Shizheng Zhang, Mengmeng Li, Yuan Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Proteomic Analysis of Substantia Nigra Reveals Molecular Insights Into the Neuroprotection Effect of Rosmarinic Acid Treatment in MPTP‐Induced Mouse Model of Parkinson's Disease
Sarah Martins Presti‐Silva, Lucas Rodrigues‐Ribeiro, Vladimir Gorshkov, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2025)
Closed Access
JAC4 Alleviates Rotenone-Induced Parkinson’s Disease through the Inactivation of the NLRP3 Signal Pathway
Lu Zou, Zhen Che, Kun Ding, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1134-1134
Open Access | Times Cited: 9
Chronic Cocaine Use and Parkinson’s Disease: An Interpretative Model
Manuel Glauco Carbone, Icro Maremmani
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 8, pp. 1105-1105
Open Access | Times Cited: 3
A reversible state of hypometabolism in a human cellular model of sporadic Parkinson’s disease
Sebastian Schmidt, Constantin Stautner, Duc Tung Vu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system
Steinunn Sara Helgudóttir, Anne Skøttrup Mørkholt, Jacek Lichota, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1437-1445
Open Access | Times Cited: 6
A Mitochondrial Perspective on Noncommunicable Diseases
Yifan Zheng, Jing Zhang, Xiaohong Zhu, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 647-647
Open Access | Times Cited: 5
New perspectives on the role of mitochondria in Parkinson's disease
Shiyi Yin, Yongjiang Zhang, Jiannan Wu, et al.
Journal of Neurorestoratology (2024) Vol. 12, Iss. 2, pp. 100112-100112
Open Access | Times Cited: 1
β-Synuclein Intermediates α-Synuclein Neurotoxicity in Parkinson’s Disease
Meiyan Xian, Jingwen Li, Tingting Liu, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 13, pp. 2445-2453
Closed Access | Times Cited: 1
Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease
Alika Sarkar, Mohd Sami ur Rasheed, Mahendra Pratap Singh
Antioxidants and Redox Signaling (2022) Vol. 38, Iss. 10-12, pp. 824-852
Closed Access | Times Cited: 6
Isolation of Lessertiosides A and B and Other Metabolites from Lessertia frutescens and Their Neuroprotection Activity
Kadidiatou O. Ndjoubi, Sylvester I. Omoruyi, Robert C. Luckay, et al.
Plants (2024) Vol. 13, Iss. 21, pp. 3076-3076
Open Access
The MitoPark mouse model of Parkinson's disease
Nada Yasser, Aya Haggag, Nourhan Abdelfatah Ahmed, et al.
Elsevier eBooks (2024), pp. 167-185
Closed Access
Chemoproteomic profiling by bioorthogonal probes to reveal the novel targets of acrylamide in microglia
Binru Zheng, Jia Shang, Yuanqing Wei, et al.
Journal of Hazardous Materials (2024) Vol. 484, pp. 136760-136760
Closed Access
Effects of fluoride on oxidative DNA damage, nitric oxide level, lipid peroxidation and cholinesterase enzyme activity in a rotenone-induced experimental Parkinson’s model
Yılmaz KOÇAK, Gökhan Oto, Zübeyir Huyut, et al.
Neurological Research (2023) Vol. 45, Iss. 11, pp. 979-987
Closed Access
Page 1

Scroll to top